News search

    E.g., 22/06/2026
    E.g., 22/06/2026
    Optimal dendritic-cell-based antitumor immunotherapy with cDC1 cells requires active mitochondria. Whereas vaccination with normal cDC1 cells efficiently reduces metastasis in B16-OVA tumors, the antitumor efficacy of these cells is diminished when their mitochondria are damaged.
    Research
    22 May 2026
    Science Immunology: Mitochondria control immune cell activation and the effectiveness of immunotherapy

    A CNIC-led study identifies a mitochondrial “checkpoint” that enables dendritic cells to efficiently activate T lymphocytes against viruses and tumors
    Francesco Costa
    Research
    18 May 2026
    Dr. Francesco Costa: "The sustained use of tools like ChatGPT produces a phenomenon called deskilling"
    Jennifer Davis
    Research
    6 May 2026
    Jennifer Davis: "We need to treat IA as a tool for generating hypotheses, not final answers"
    Anthony Firulli
    Research
    5 May 2026
    Anthony Firulli: "My goal is to spend as many days as possible with a smile on my face"
    Faseeha Ayaz
    Research
    30 Apr 2026
    Faseeha Ayaz: "I would say the editors are very much on the researchers’ side"

    Faseeha Ayaz, senior Editor Nature Communications, Springer Nature
    About the CNIC
    27 Apr 2026
    The First 2026 Competitive Call for Unique Scientific and Technical Infrastructures of the Distributed Biomedical Imaging Network (ReDIB) Is Now Open
    Job Verdonschot, Maastricht University Medical Center, and the Cardiovascular Research Institute Maastricht
    Research
    23 Apr 2026
    Job Verdonschot: "The next challenge is the full integration of genetics into cardiology training programs"

    Job Verdonschot, Maastricht University Medical Center, and the Cardiovascular Research Institute Maastricht
    Dr. Pablo García-Pavía junto con la Dra. Noelia Mora y la Dra. Belén Peiró
    Research
    21 Apr 2026
    CNIC scientists identify a biomarker that improves risk prediction in a severe form of heart failure

    The biomarker MR-proADM improves risk prediction in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) and is associated with greater disease severity, mortality, and heart failure events.
    Michael Reth profesor de Inmunología Molecular en la Universidad de Friburgo
    Research
    17 Apr 2026
    Michael Reth: “People with dyslexia are specialized to explore the unknown”
    David Sancho, Ignacio Heras-Murillo y Stefanie Wculek.
    Research
    15 Apr 2026
    Mitochondria keep immune cells “ready to respond”

    Scientist at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) and the Institute for Research in Biomedicine (IRB Barcelona) uncover a key metabolic mechanism governing immune cell readiness